The global market for Diagnostic Imaging Marker was valued at US$ 1352 million in the year 2024 and is projected to reach a revised size of US$ 2172 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Diagnostic Imaging Marker Market

Diagnostic imaging markers are agents or devices designed to enhance the visualization of lesions across medical imaging modalities such as X-ray, CT, MRI, ultrasound, and nuclear medicine. They include contrast media, radiotracers, MRI contrast agents, ultrasound microbubbles, and intraoperative or interventional markers used for lesion localization. Their primary functions are to improve lesion contrast, aid in localization and staging, assess functional and metabolic status, and guide surgical or interventional procedures—directly influencing diagnostic accuracy and therapeutic decision-making. With the rise of molecular imaging, radiomics, and theranostics, imaging markers are evolving from single-purpose contrast enhancers into multifunctional platforms that integrate diagnosis, phenotyping, and treatment-guidance, serving as essential connectors across radiology, oncology, interventional, and surgical care pathways.The average gross profit margin of this product is 65%.

With the continuous improvement of global healthcare and rapid iteration of imaging technologies, the diagnostic imaging marker market has encountered unprecedented development opportunities. The rise of precision medicine and personalized therapy has driven an increasing demand for high-sensitivity and high-specificity imaging markers. At the same time, growing needs for early screening of cancer, cardiovascular, and neurological diseases have prompted healthcare institutions and research centers to invest more in high-quality markers. Furthermore, interdisciplinary technological integration, such as molecular imaging combined with artificial intelligence, provides new application scenarios and value enhancement opportunities for diagnostic imaging markers. Supportive policies and gradually improved regulatory frameworks also offer a solid foundation for healthy industry growth.

Despite significant market potential, the diagnostic imaging marker industry faces multiple challenges. Long R&D cycles, high technical barriers, and stringent clinical validation requirements necessitate substantial investment of capital and resources before new product launches. Meanwhile, significant differences in medical regulatory policies across regions make product approval and market entry complex, increasing compliance risks for companies. Fluctuations in raw material prices, supply chain disruptions, and reliance on a limited number of suppliers for critical technologies can also impact production and profitability. Moreover, as market competition intensifies, companies must continue investing in innovation, brand development, and service support to maintain a competitive edge.

As healthcare institutions increasingly focus on early diagnosis and precision therapy, clinical demand for diagnostic imaging markers is showing steady growth. Hospitals, imaging centers, and research institutions are gradually shifting from generic markers to high-value, customized molecular imaging markers to meet the needs of different disease types and individualized patient care. The reliance of pharmaceutical and research companies on high-sensitivity markers during drug development is also increasing, creating new growth opportunities for the industry. Furthermore, the rising frequency of imaging examinations and the widespread adoption of multi-modal imaging will further drive downstream market expansion.

The production of diagnostic imaging markers relies on high-purity chemical reagents, specific biomolecular carriers, and highly stable fluorescent or radioactive isotopes as key raw materials. The quality and stability of raw materials directly affect the imaging performance and safety of markers, making reliability and traceability critical considerations when selecting supply chain partners. Additionally, raw material pricing and technological innovation capabilities are key factors for cost control and product differentiation. As demand for high-performance markers grows, upstream suppliers are continuously optimizing production processes and improving the purity and functionalization of raw materials, providing robust support for downstream enterprises.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Imaging Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Imaging Marker.

The Diagnostic Imaging Marker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Imaging Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, by Imaging Modality and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Imaging Marker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diagnostic Imaging Marker Market Report

Report Metric	Details
Report Name	Diagnostic Imaging Marker Market
Accounted market size in year	US$ 1352 million
Forecasted market size in 2031	US$ 2172 million
CAGR	7.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Small-Molecule Contrast Agents Radiotracers Other
Segment by Imaging Modality	CT Contrast Agents MRI Contrast Agents Nuclear Medicine Tracers Other
Segment by Administration	Intravenous (IV) Administration Local Injection/Perfusion Oral Contrast
Segment by Application	Hospital Image Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng, Seed Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Imaging Modality etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Imaging Marker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Imaging Marker Market growing?

Ans: The Diagnostic Imaging Marker Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Diagnostic Imaging Marker Market size in 2031?

Ans: The Diagnostic Imaging Marker Market size in 2031 will be US$ 2172 million.

Who are the main players in the Diagnostic Imaging Marker Market report?

Ans: The main players in the Diagnostic Imaging Marker Market are Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng, Seed Medical

What are the Application segmentation covered in the Diagnostic Imaging Marker Market report?

Ans: The Applications covered in the Diagnostic Imaging Marker Market report are Hospital, Image Center, Other

What are the Type segmentation covered in the Diagnostic Imaging Marker Market report?

Ans: The Types covered in the Diagnostic Imaging Marker Market report are Small-Molecule Contrast Agents, Radiotracers, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diagnostic Imaging Marker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small-Molecule Contrast Agents

1.2.3 Radiotracers

1.2.4 Other

1.3 Market by Imaging Modality

1.3.1 Global Diagnostic Imaging Marker Market Size Growth Rate by Imaging Modality: 2020 VS 2024 VS 2031

1.3.2 CT Contrast Agents

1.3.3 MRI Contrast Agents

1.3.4 Nuclear Medicine Tracers

1.3.5 Other

1.4 Market by Administration

1.4.1 Global Diagnostic Imaging Marker Market Size Growth Rate by Administration: 2020 VS 2024 VS 2031

1.4.2 Intravenous (IV) Administration

1.4.3 Local Injection/Perfusion

1.4.4 Oral Contrast

1.5 Market by Application

1.5.1 Global Diagnostic Imaging Marker Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Image Center

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Diagnostic Imaging Marker Market Perspective (2020-2031)

2.2 Global Diagnostic Imaging Marker Growth Trends by Region

2.2.1 Global Diagnostic Imaging Marker Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Diagnostic Imaging Marker Historic Market Size by Region (2020-2025)

2.2.3 Diagnostic Imaging Marker Forecasted Market Size by Region (2026-2031)

2.3 Diagnostic Imaging Marker Market Dynamics

2.3.1 Diagnostic Imaging Marker Industry Trends

2.3.2 Diagnostic Imaging Marker Market Drivers

2.3.3 Diagnostic Imaging Marker Market Challenges

2.3.4 Diagnostic Imaging Marker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diagnostic Imaging Marker Players by Revenue

3.1.1 Global Top Diagnostic Imaging Marker Players by Revenue (2020-2025)

3.1.2 Global Diagnostic Imaging Marker Revenue Market Share by Players (2020-2025)

3.2 Global Top Diagnostic Imaging Marker Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diagnostic Imaging Marker Revenue

3.4 Global Diagnostic Imaging Marker Market Concentration Ratio

3.4.1 Global Diagnostic Imaging Marker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Imaging Marker Revenue in 2024

3.5 Global Key Players of Diagnostic Imaging Marker Head office and Area Served

3.6 Global Key Players of Diagnostic Imaging Marker, Product and Application

3.7 Global Key Players of Diagnostic Imaging Marker, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Imaging Marker Breakdown Data by Type

4.1 Global Diagnostic Imaging Marker Historic Market Size by Type (2020-2025)

4.2 Global Diagnostic Imaging Marker Forecasted Market Size by Type (2026-2031)

5 Diagnostic Imaging Marker Breakdown Data by Application

5.1 Global Diagnostic Imaging Marker Historic Market Size by Application (2020-2025)

5.2 Global Diagnostic Imaging Marker Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Diagnostic Imaging Marker Market Size (2020-2031)

6.2 North America Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Diagnostic Imaging Marker Market Size by Country (2020-2025)

6.4 North America Diagnostic Imaging Marker Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diagnostic Imaging Marker Market Size (2020-2031)

7.2 Europe Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Diagnostic Imaging Marker Market Size by Country (2020-2025)

7.4 Europe Diagnostic Imaging Marker Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Diagnostic Imaging Marker Market Size (2020-2031)

8.2 Asia-Pacific Diagnostic Imaging Marker Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2020-2025)

8.4 Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Diagnostic Imaging Marker Market Size (2020-2031)

9.2 Latin America Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Diagnostic Imaging Marker Market Size by Country (2020-2025)

9.4 Latin America Diagnostic Imaging Marker Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diagnostic Imaging Marker Market Size (2020-2031)

10.2 Middle East & Africa Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2020-2025)

10.4 Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cardinal Health

11.1.1 Cardinal Health Company Details

11.1.2 Cardinal Health Business Overview

11.1.3 Cardinal Health Diagnostic Imaging Marker Introduction

11.1.4 Cardinal Health Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.1.5 Cardinal Health Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Diagnostic Imaging Marker Introduction

11.2.4 GE Healthcare Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.2.5 GE Healthcare Recent Development

11.3 Lantheus Medical Imaging

11.3.1 Lantheus Medical Imaging Company Details

11.3.2 Lantheus Medical Imaging Business Overview

11.3.3 Lantheus Medical Imaging Diagnostic Imaging Marker Introduction

11.3.4 Lantheus Medical Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.3.5 Lantheus Medical Imaging Recent Development

11.4 Bracco Imaging

11.4.1 Bracco Imaging Company Details

11.4.2 Bracco Imaging Business Overview

11.4.3 Bracco Imaging Diagnostic Imaging Marker Introduction

11.4.4 Bracco Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.4.5 Bracco Imaging Recent Development

11.5 Curium Pharma

11.5.1 Curium Pharma Company Details

11.5.2 Curium Pharma Business Overview

11.5.3 Curium Pharma Diagnostic Imaging Marker Introduction

11.5.4 Curium Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.5.5 Curium Pharma Recent Development

11.6 Jubilant Pharmova

11.6.1 Jubilant Pharmova Company Details

11.6.2 Jubilant Pharmova Business Overview

11.6.3 Jubilant Pharmova Diagnostic Imaging Marker Introduction

11.6.4 Jubilant Pharmova Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.6.5 Jubilant Pharmova Recent Development

11.7 Aurobindo Pharma

11.7.1 Aurobindo Pharma Company Details

11.7.2 Aurobindo Pharma Business Overview

11.7.3 Aurobindo Pharma Diagnostic Imaging Marker Introduction

11.7.4 Aurobindo Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.7.5 Aurobindo Pharma Recent Development

11.8 Siemens

11.8.1 Siemens Company Details

11.8.2 Siemens Business Overview

11.8.3 Siemens Diagnostic Imaging Marker Introduction

11.8.4 Siemens Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.8.5 Siemens Recent Development

11.9 NTP Radioisotopes

11.9.1 NTP Radioisotopes Company Details

11.9.2 NTP Radioisotopes Business Overview

11.9.3 NTP Radioisotopes Diagnostic Imaging Marker Introduction

11.9.4 NTP Radioisotopes Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.9.5 NTP Radioisotopes Recent Development

11.10 ANSTO

11.10.1 ANSTO Company Details

11.10.2 ANSTO Business Overview

11.10.3 ANSTO Diagnostic Imaging Marker Introduction

11.10.4 ANSTO Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.10.5 ANSTO Recent Development

11.11 Polatom

11.11.1 Polatom Company Details

11.11.2 Polatom Business Overview

11.11.3 Polatom Diagnostic Imaging Marker Introduction

11.11.4 Polatom Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.11.5 Polatom Recent Development

11.12 China Isotope & Radiation

11.12.1 China Isotope & Radiation Company Details

11.12.2 China Isotope & Radiation Business Overview

11.12.3 China Isotope & Radiation Diagnostic Imaging Marker Introduction

11.12.4 China Isotope & Radiation Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.12.5 China Isotope & Radiation Recent Development

11.13 Yantai Dongcheng

11.13.1 Yantai Dongcheng Company Details

11.13.2 Yantai Dongcheng Business Overview

11.13.3 Yantai Dongcheng Diagnostic Imaging Marker Introduction

11.13.4 Yantai Dongcheng Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.13.5 Yantai Dongcheng Recent Development

11.14 Seed Medical

11.14.1 Seed Medical Company Details

11.14.2 Seed Medical Business Overview

11.14.3 Seed Medical Diagnostic Imaging Marker Introduction

11.14.4 Seed Medical Revenue in Diagnostic Imaging Marker Business (2020-2025)

11.14.5 Seed Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cardinal Health

GE Healthcare

Lantheus Medical Imaging

China Isotope & Radiation

Yantai Dongcheng

Seed Medical

List of Tables

Table 1. Global Diagnostic Imaging Marker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small-Molecule Contrast Agents

Table 3. Key Players of Radiotracers

Table 4. Key Players of Other

Table 5. Global Diagnostic Imaging Marker Market Size Growth Rate by Imaging Modality (US$ Million): 2020 VS 2024 VS 2031

Table 6. Key Players of CT Contrast Agents

Table 7. Key Players of MRI Contrast Agents

Table 8. Key Players of Nuclear Medicine Tracers

Table 9. Key Players of Other

Table 10. Global Diagnostic Imaging Marker Market Size Growth Rate by Administration (US$ Million): 2020 VS 2024 VS 2031

Table 11. Key Players of Intravenous (IV) Administration

Table 12. Key Players of Local Injection/Perfusion

Table 13. Key Players of Oral Contrast

Table 14. Global Diagnostic Imaging Marker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Diagnostic Imaging Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Diagnostic Imaging Marker Market Size by Region (2020-2025) & (US$ Million)

Table 17. Global Diagnostic Imaging Marker Market Share by Region (2020-2025)

Table 18. Global Diagnostic Imaging Marker Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 19. Global Diagnostic Imaging Marker Market Share by Region (2026-2031)

Table 20. Diagnostic Imaging Marker Market Trends

Table 21. Diagnostic Imaging Marker Market Drivers

Table 22. Diagnostic Imaging Marker Market Challenges

Table 23. Diagnostic Imaging Marker Market Restraints

Table 24. Global Diagnostic Imaging Marker Revenue by Players (2020-2025) & (US$ Million)

Table 25. Global Diagnostic Imaging Marker Market Share by Players (2020-2025)

Table 26. Global Top Diagnostic Imaging Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Marker as of 2024)

Table 27. Ranking of Global Top Diagnostic Imaging Marker Companies by Revenue (US$ Million) in 2024

Table 28. Global 5 Largest Players Market Share by Diagnostic Imaging Marker Revenue (CR5 and HHI) & (2020-2025)

Table 29. Global Key Players of Diagnostic Imaging Marker, Headquarters and Area Served

Table 30. Global Key Players of Diagnostic Imaging Marker, Product and Application

Table 31. Global Key Players of Diagnostic Imaging Marker, Date of Enter into This Industry

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Diagnostic Imaging Marker Market Size by Type (2020-2025) & (US$ Million)

Table 34. Global Diagnostic Imaging Marker Revenue Market Share by Type (2020-2025)

Table 35. Global Diagnostic Imaging Marker Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 36. Global Diagnostic Imaging Marker Revenue Market Share by Type (2026-2031)

Table 37. Global Diagnostic Imaging Marker Market Size by Application (2020-2025) & (US$ Million)

Table 38. Global Diagnostic Imaging Marker Revenue Market Share by Application (2020-2025)

Table 39. Global Diagnostic Imaging Marker Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 40. Global Diagnostic Imaging Marker Revenue Market Share by Application (2026-2031)

Table 41. North America Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. North America Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)

Table 43. North America Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)

Table 44. Europe Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Europe Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)

Table 46. Europe Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)

Table 47. Asia-Pacific Diagnostic Imaging Marker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 48. Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2020-2025) & (US$ Million)

Table 49. Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2026-2031) & (US$ Million)

Table 50. Latin America Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Latin America Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)

Table 52. Latin America Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)

Table 53. Middle East & Africa Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)

Table 55. Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)

Table 56. Cardinal Health Company Details

Table 57. Cardinal Health Business Overview

Table 58. Cardinal Health Diagnostic Imaging Marker Product

Table 59. Cardinal Health Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 60. Cardinal Health Recent Development

Table 61. GE Healthcare Company Details

Table 62. GE Healthcare Business Overview

Table 63. GE Healthcare Diagnostic Imaging Marker Product

Table 64. GE Healthcare Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 65. GE Healthcare Recent Development

Table 66. Lantheus Medical Imaging Company Details

Table 67. Lantheus Medical Imaging Business Overview

Table 68. Lantheus Medical Imaging Diagnostic Imaging Marker Product

Table 69. Lantheus Medical Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 70. Lantheus Medical Imaging Recent Development

Table 71. Bracco Imaging Company Details

Table 72. Bracco Imaging Business Overview

Table 73. Bracco Imaging Diagnostic Imaging Marker Product

Table 74. Bracco Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 75. Bracco Imaging Recent Development

Table 76. Curium Pharma Company Details

Table 77. Curium Pharma Business Overview

Table 78. Curium Pharma Diagnostic Imaging Marker Product

Table 79. Curium Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 80. Curium Pharma Recent Development

Table 81. Jubilant Pharmova Company Details

Table 82. Jubilant Pharmova Business Overview

Table 83. Jubilant Pharmova Diagnostic Imaging Marker Product

Table 84. Jubilant Pharmova Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 85. Jubilant Pharmova Recent Development

Table 86. Aurobindo Pharma Company Details

Table 87. Aurobindo Pharma Business Overview

Table 88. Aurobindo Pharma Diagnostic Imaging Marker Product

Table 89. Aurobindo Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 90. Aurobindo Pharma Recent Development

Table 91. Siemens Company Details

Table 92. Siemens Business Overview

Table 93. Siemens Diagnostic Imaging Marker Product

Table 94. Siemens Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 95. Siemens Recent Development

Table 96. NTP Radioisotopes Company Details

Table 97. NTP Radioisotopes Business Overview

Table 98. NTP Radioisotopes Diagnostic Imaging Marker Product

Table 99. NTP Radioisotopes Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 100. NTP Radioisotopes Recent Development

Table 101. ANSTO Company Details

Table 102. ANSTO Business Overview

Table 103. ANSTO Diagnostic Imaging Marker Product

Table 104. ANSTO Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 105. ANSTO Recent Development

Table 106. Polatom Company Details

Table 107. Polatom Business Overview

Table 108. Polatom Diagnostic Imaging Marker Product

Table 109. Polatom Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 110. Polatom Recent Development

Table 111. China Isotope & Radiation Company Details

Table 112. China Isotope & Radiation Business Overview

Table 113. China Isotope & Radiation Diagnostic Imaging Marker Product

Table 114. China Isotope & Radiation Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 115. China Isotope & Radiation Recent Development

Table 116. Yantai Dongcheng Company Details

Table 117. Yantai Dongcheng Business Overview

Table 118. Yantai Dongcheng Diagnostic Imaging Marker Product

Table 119. Yantai Dongcheng Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 120. Yantai Dongcheng Recent Development

Table 121. Seed Medical Company Details

Table 122. Seed Medical Business Overview

Table 123. Seed Medical Diagnostic Imaging Marker Product

Table 124. Seed Medical Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)

Table 125. Seed Medical Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Diagnostic Imaging Marker Picture

Figure 2. Global Diagnostic Imaging Marker Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diagnostic Imaging Marker Market Share by Type: 2024 VS 2031

Figure 4. Small-Molecule Contrast Agents Features

Figure 5. Radiotracers Features

Figure 6. Other Features

Figure 7. Global Diagnostic Imaging Marker Market Size Comparison by Imaging Modality (2020-2031) & (US$ Million)

Figure 8. CT Contrast Agents Features

Figure 9. MRI Contrast Agents Features

Figure 10. Nuclear Medicine Tracers Features

Figure 11. Other Features

Figure 12. Global Diagnostic Imaging Marker Market Size Comparison by Administration (2020-2031) & (US$ Million)

Figure 13. Intravenous (IV) Administration Features

Figure 14. Local Injection/Perfusion Features

Figure 15. Oral Contrast Features

Figure 16. Global Diagnostic Imaging Marker Market Size by Application (2020-2031) & (US$ Million)

Figure 17. Global Diagnostic Imaging Marker Market Share by Application: 2024 VS 2031

Figure 18. Hospital Case Studies

Figure 19. Image Center Case Studies

Figure 20. Other Case Studies

Figure 21. Diagnostic Imaging Marker Report Years Considered

Figure 22. Global Diagnostic Imaging Marker Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Diagnostic Imaging Marker Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Diagnostic Imaging Marker Market Share by Region: 2024 VS 2031

Figure 25. Global Diagnostic Imaging Marker Market Share by Players in 2024

Figure 26. Global Diagnostic Imaging Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by Diagnostic Imaging Marker Revenue in 2024

Figure 28. North America Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Diagnostic Imaging Marker Market Share by Country (2020-2031)

Figure 30. United States Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Diagnostic Imaging Marker Market Share by Country (2020-2031)

Figure 34. Germany Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Ireland Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Diagnostic Imaging Marker Market Share by Region (2020-2031)

Figure 42. China Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia & New Zealand Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Diagnostic Imaging Marker Market Share by Country (2020-2031)

Figure 50. Mexico Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Diagnostic Imaging Marker Market Share by Country (2020-2031)

Figure 54. Israel Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Cardinal Health Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 58. GE Healthcare Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 59. Lantheus Medical Imaging Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 60. Bracco Imaging Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 61. Curium Pharma Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 62. Jubilant Pharmova Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 63. Aurobindo Pharma Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 64. Siemens Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 65. NTP Radioisotopes Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 66. ANSTO Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 67. Polatom Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 68. China Isotope & Radiation Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 69. Yantai Dongcheng Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 70. Seed Medical Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions